Burden, Mortality and Supply Costs in Intensive Care Unit Patients

Launched by UNIVERSITY OF ULM · Sep 17, 2019

Keywords

ClinConnect Summary

This clinical trial, titled "Burden, Mortality and Supply Costs in Intensive Care Unit Patients," is focused on understanding how different treatment strategies in the Intensive Care Unit (ICU) affect patients who are critically ill. Researchers will look at three groups of patients based on their initial health risks (high, intermediate, and low) to see how these strategies influence three main outcomes: patient burden (how much stress and discomfort they experience), mortality (the chance of death), and supply costs (the expenses related to their care). The trial aims to gather real-world data to help improve end-of-life care for patients in the ICU.

To be eligible for the study, patients must either be expected to die in the ICU or have stayed in the ICU for at least 72 hours. There are no specific exclusions, so anyone who meets these criteria can be considered. If a patient participates, they can expect to contribute to important research that could help shape future ICU treatment approaches. This study is currently recruiting participants, and it includes all adults, regardless of gender. Your involvement could help better understand the challenges faced by ICU patients and improve care for others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All patients dying on the ICU and all patients staying for at least 72 hours on the ICU
• Exclusion Criteria:
• • No